Stay updated on Pimavanserin Safety in Neurodegenerative Disease Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T16:23:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T03:31:12.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been changed to 'Here’s how you know', which does not alter the meaning.
    Difference
    1.0%
    Check dated 2025-04-16T14:21:52.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 31, 2024.
    Difference
    1%
    Check dated 2025-04-09T09:12:21.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:54:48.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:54:12.000Z thumbnail image

Stay in the know with updates to Pimavanserin Safety in Neurodegenerative Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.